<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01041183</url>
  </required_header>
  <id_info>
    <org_study_id>nasea-LC</org_study_id>
    <nct_id>NCT01041183</nct_id>
  </id_info>
  <brief_title>The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <brief_summary>
    <textblock>
      Patients undergoing general anesthesia for laparoscopic cholecystectomy have a high risk of
      postoperative nausea and vomiting (PONV). The investigators investigated the effect of oral
      and IV ramosetron on PONV prophylaxis after laparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of PONV</measure>
    <time_frame>postoperative 0-48 h</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <condition>Laparoscopic Cholecystectomy</condition>
  <arm_group>
    <arm_group_label>group I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.3 mg IV ramosetron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.1 mg oral ramosetron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group III</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.1 mg oral ramosetron plus 0.3 mg IV ramosetron</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous ramosetron</intervention_name>
    <description>0.3 mg IV ramosetron (group I)</description>
    <arm_group_label>group I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral ramosetron</intervention_name>
    <description>0.1 mg oral ramosetron (group II)</description>
    <arm_group_label>group II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral and IV ramosetron</intervention_name>
    <description>0.1 mg oral ramosetron plus 0.3 mg IV ramosetron (group III).</description>
    <arm_group_label>group III</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II patients, 25-65 years, electivelaparoscopic cholecystectomy under general
             anesthesia

        Exclusion Criteria:

          -  GI disease, pregnant or menstruating, history of motion sickness and/or postoperative
             emesis, antiemetics within 24 h before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jung-Hee Ryu, Ph.D</last_name>
    <phone>82-31-787-7497</phone>
    <email>jinaryu@lycos.co.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jung-Hee Ryu</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung-Hee Ryu, Ph.D</last_name>
      <phone>82-31-787-7497</phone>
      <email>jinaryu@lycos.co.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2009</study_first_submitted>
  <study_first_submitted_qc>December 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2009</study_first_posted>
  <last_update_submitted>December 30, 2009</last_update_submitted>
  <last_update_submitted_qc>December 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 31, 2009</last_update_posted>
  <responsible_party>
    <name_title>Seoul National University Bundang Hospital</name_title>
    <organization>Seoul National University Bundang Hospital</organization>
  </responsible_party>
  <keyword>Oral plus IV ramosetron may be more effective than</keyword>
  <keyword>IV ramosetron and oral ramosetron for the prophylaxis of</keyword>
  <keyword>PONV after laparoscopic cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ramosetron</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>July 23, 2010</submitted>
    <returned>August 18, 2010</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

